SecSonar.com

Valneva SE (VALN)

Valneva SE at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Valneva SE (VALN) is a Biotechnology company based in FR with a market capitalization of $563.3M. Revenue grew 3.0% year-over-year and free cash flow was negative at -$65.6M. This page tracks VALN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

FR · 713 employees · IPO May 5, 2021

Valuation

Valuation & price

$5.68 · as of May 17, 2026 · -53.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.31

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$12.14$8.67$5.19Jul 25Dec 25Jun 26Jul 7, 25$5.74Jul 9, 25$5.90Jul 11, 25$6.07Jul 15, 25$6.45Jul 17, 25$6.50Jul 21, 25$6.35Jul 23, 25$7.32Jul 25, 25$7.68Jul 29, 25$7.76Jul 31, 25$7.35Aug 4, 25$7.50Aug 6, 25$8.19Aug 8, 25$9.11Aug 12, 25$9.40Aug 14, 25$10.47Aug 18, 25$12.14Aug 20, 25$11.50Aug 22, 25$11.64Aug 26, 25$8.96Aug 28, 25$8.84Sep 3, 25$8.77Sep 5, 25$8.65Sep 9, 25$8.93Sep 11, 25$9.18Sep 15, 25$8.93Sep 17, 25$9.97Sep 19, 25$10.18Sep 23, 25$10.03Sep 25, 25$9.95Sep 29, 25$10.95Oct 1, 25$11.57Oct 3, 25$11.39Oct 7, 25$10.65Oct 9, 25$11.14Oct 13, 25$10.50Oct 15, 25$10.50Oct 17, 25$10.04Oct 21, 25$9.87Oct 23, 25$9.68Oct 27, 25$9.26Oct 30, 25$9.13Nov 3, 25$9.05Nov 5, 25$9.00Nov 7, 25$8.72Nov 11, 25$8.89Nov 13, 25$9.23Nov 17, 25$8.89Nov 19, 25$8.70Nov 21, 25$8.62Nov 25, 25$8.74Nov 28, 25$9.36Dec 2, 25$8.77Dec 4, 25$8.84Dec 8, 25$8.92Dec 10, 25$8.88Dec 12, 25$8.68Dec 16, 25$8.34Dec 18, 25$8.14Dec 22, 25$8.46Dec 24, 25$8.49Dec 29, 25$8.79Jan 2, 26$8.96Jan 6, 26$9.75Jan 8, 26$9.75Jan 12, 26$9.76Jan 14, 26$10.37Jan 16, 26$10.07Jan 21, 26$9.92Jan 23, 26$9.77Jan 27, 26$9.62Jan 29, 26$9.41Feb 2, 26$9.15Feb 4, 26$9.56Feb 6, 26$9.49Feb 10, 26$9.83Feb 12, 26$10.02Feb 17, 26$10.77Feb 19, 26$10.49Feb 23, 26$11.44Feb 25, 26$11.41Mar 2, 26$10.92Mar 4, 26$10.97Mar 6, 26$10.52Mar 10, 26$11.39Mar 12, 26$10.48Mar 16, 26$10.51Mar 18, 26$11.19Mar 20, 26$10.32Mar 24, 26$6.42Mar 26, 26$6.32Mar 30, 26$6.19Apr 1, 26$6.27Apr 6, 26$5.96Apr 8, 26$6.25Apr 10, 26$6.18Apr 14, 26$6.09Apr 16, 26$5.97Apr 20, 26$6.04Apr 22, 26$5.25Apr 24, 26$5.50Apr 28, 26$5.53May 1, 26$5.35May 5, 26$5.29May 7, 26$5.56May 11, 26$6.30May 13, 26$5.87May 15, 26$5.68May 19, 26$5.76May 21, 26$5.87May 26, 26$6.05May 28, 26$6.30Jun 1, 26$5.95Jun 3, 26$5.58Jun 5, 26$5.48Jun 9, 26$5.31Jun 11, 26$5.29Jun 15, 26$5.39Jun 17, 26$5.35Jun 22, 26$5.35Jun 26, 26$5.19
$5.1752-week range$12.20
Loading valuation history…

Fundamentals

Key fundamentals

$563.3M

Market cap

3.0%

Revenue growth (YoY)

38.7%

Gross margin

-$65.6M

Free cash flow (USD)

$97.6M

Net debt

19.7%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$94.1MFY 2017$105.3MFY 2018$113.0MFY 2019$126.2MFY 2020$110.3MFY 2021$348.1MFY 2022$361.3MFY 2023$153.7MFY 2024$169.6MFY 2025$174.7M
$94.1M$174.7M

Free cash flow by year

2016 → 2025

FY 2016$2.8MFY 2017$8.8MFY 2018$13.1MFY 2019$-5.4MFY 2020$118.3MFY 2021$-16.3MFY 2022$-274.7MFY 2023$-217.1MFY 2024$-83.7MFY 2025$-57.4M
$2.8M-$57.4M

Gross margin by year

2021 → 2025

FY 202146.0%FY 202210.2%FY 202334.4%FY 202441.9%FY 202538.7%
46.0%38.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingAnnual General Meeting ResultsJun 25, 2026Filing
  • 6-K filingAnnual General Meeting DocumentationJun 5, 2026Filing
  • 6-K filingInvestor Conferences ParticipationJun 1, 2026Filing
  • Annual reportAnnual Report FiledMay 13, 2026Filing
  • 6-K filingFinancial Results AnnouncementMay 5, 2026Filing
  • 6-K filingSecurities Purchase AgreementApr 30, 2026Filing

Questions

Frequently asked questions

What is Valneva SE's market cap?

Valneva SE (VALN) has a market capitalization of $563.3M.

What is VALN's P/E ratio?

A meaningful P/E ratio is not available for VALN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is VALN's price-to-book (P/B) ratio?

VALN trades at 5.31 times book value per share.

Are insiders buying VALN stock?

SEC Form 4 filings show no open-market insider buys at Valneva SE in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

RIGL

Rigel Pharmaceuticals, Inc.

$562.1M

ARVN

Arvinas, Inc.

$572M

GYRE

Gyre Therapeutics, Inc.

$572.7M

MDXG

MiMedx Group, Inc.

$553.3M

ACRS

Aclaris Therapeutics, Inc.

$546.3M

CTMX

CytomX Therapeutics, Inc.

$582.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.